You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 050781

✉ Email this page to a colleague

NDA 050781 describes ARESTIN, which is a drug marketed by Orapharma and is included in one NDA. It is available from one supplier. Additional details are available on the ARESTIN profile page.

The generic ingredient in ARESTIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Summary for 050781

Tradename:	ARESTIN
Applicant:	Orapharma
Ingredient:	minocycline hydrochloride
Patents:	0

Pharmacology for NDA: 050781

Physiological Effect	Decreased Prothrombin Activity

Medical Subject Heading (MeSH) Categories for 050781

Anti-Bacterial Agents

Suppliers and Packaging for NDA: 050781

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781	NDA	OraPharma, Inc.	65976-100	65976-100-01	1 POWDER in 1 POUCH (65976-100-01)
ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781	NDA	OraPharma, Inc.	65976-100	65976-100-12	1 POUCH in 1 BOX (65976-100-12) / 1 TRAY in 1 POUCH / 12 POWDER in 1 TRAY

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	POWDER, EXTENDED RELEASE;DENTAL			Strength	EQ 1MG BASE
Approval Date:	Feb 16, 2001	TE:		RLD:	Yes

Expired US Patents for NDA 050781

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001	⤷ Get Started Free	⤷ Get Started Free
Orapharma	ARESTIN	minocycline hydrochloride	POWDER, EXTENDED RELEASE;DENTAL	050781-001	Feb 16, 2001	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.